Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $26.1 Million - $30 Million
-435,000 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$59.94 - $65.35 $18 Million - $19.6 Million
300,000 Added 222.22%
435,000 $26.7 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $7.46 Million - $8.6 Million
135,000
135,000 $8.61 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track K2 Principal Fund, L.P. Portfolio

Follow K2 Principal Fund, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

News

Stay updated on K2 Principal Fund, L.P. with notifications on news.